Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial - The Lancet

Por um escritor misterioso
Last updated 16 junho 2024
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Design and Preclinical Characterization Program toward Asundexian
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
PDF) The new era of anticoagulation: factor XI and XII inhibitors
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Factor XIa inhibition with asundexian after acute non
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Full article: Atrial fibrillation and stroke
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Antithrombotic Therapy for Primary and Secondary Prevention of
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Factor XI/XIa inhibitors for the prevention and treatment of
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Ischaemic stroke despite antiplatelet therapy: Causes and outcomes
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Effects of Tablet Formulation, Food, or Gastric pH on the
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
JCDD, Free Full-Text
Factor XIa inhibition with asundexian after acute non-cardioembolic  ischaemic stroke (PACIFIC-Stroke): an international, randomised,  double-blind, placebo-controlled, phase 2b trial - The Lancet
Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC

© 2014-2024 empresaytrabajo.coop. All rights reserved.